People In The News | GenomeWeb

NEW YORK (GenomeWeb News) – Sanford-Burnham Medical Research Institute said this week that CEO John Reed is leaving his post at the institute to become head of Roche Pharma Research and Early Development and to serve on the firm's corporate executive committee. Sanford-Burnham's current President, Kristiina Vuori, will take over Reed's responsibilities on an interim basis while the institute seeks his replacement.

After the management transition process is complete, Reed will continue to hold an adjunct professor spot with the institute.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: parent-of-origin effects, framework to uncover clinically important mutations from whole genome sequence data, and more.

A survey of Cincinnati schoolchildren finds teenagers want to know their genetic predisposition to disease, LiveScience reports.

More and more universities are helping their researchers patent their inventions, the Los Angeles Times reports.

Cancer Research UK unveils seven 'grand challenges' that it will fund researchers to tackle.